Margaret Holmes-Rovner

Dr. Margaret Holmes-Rovner


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2012 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
FDFrancesca Dwamena
Francesca Dwamena
MHMargaret Holmes-Rovner
Margaret Holmes-Rovner
CGCarolyn M Gaulden
Carolyn M Gaulden
SJSarah Jorgenson
Sarah Jorgenson
GSGelareh Sadigh
Gelareh Sadigh
MBMichael Beasley
Michael Beasley

29 November 2013 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
KMKirsten J McCaffery
Kirsten J McCaffery
MHMargaret Holmes-Rovner
Margaret Holmes-Rovner
SSSian K Smith
Sian K Smith
DRDavid Rovner
David Rovner
DNDon Nutbeam
Don Nutbeam
SSStacey L Sheridan
Stacey L Sheridan
Effective use of a patient decision aid (PtDA) can be affected by the user’s health literacy and the PtDA’s characteristics. Systematic reviews of the relevant literature can guide PtDA developers to attend to the health literacy needs of patients. The reviews reported here aimed to assess:

20 June 2005 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
MHMargaret Holmes-Rovner
Margaret Holmes-Rovner
SSSue Stableford
Sue Stableford
AFAngela Fagerlin
Angela Fagerlin
JWJohn T Wei
John T Wei
RDRodney L Dunn
Rodney L Dunn
DRDavid R Rovner
David R Rovner
Background: Decision aids (DA) to assist patients in evaluating treatment options and sharing in decision making have proliferated in recent years. Most require high literacy and do not use plain language principles. We describe one of the first attempts to design a decision aid using principles from reading research and document design. The plain language DA prototype addressed treatment decisions for localized prostate cancer. Evaluation assessed impact on knowledge, decisions, and discussions with doctors in men newly diagnosed with prostate cancer. Methods: Document development steps included preparing an evidence-based DA in standard medical parlance, iteratively translating it to emphasize shared decision making and plain language in three formats (booklet, Internet, and audio-tape). Scientific review of medical content was integrated with expert health literacy review of document structure and design. Formative evaluation methods included focus groups (n = 4) and survey of a new sample of men newly diagnosed with prostate cancer (n = 60), compared with historical controls (n = 184). Results: A transparent description of the development process and design elements is reported. Formative evaluation among newly diagnosed prostate cancer patients found the DA to be clear and useful in reaching a decision. Newly diagnosed patients reported more discussions with doctors about treatment options, and showed increases in knowledge of side effects of radiation therapy. Conclusion: The plain language DA presenting medical evidence in text and numerical formats appears acceptable and useful in decision-making about localized prostate cancer treatment. Further testing should evaluate the impact of all three media on decisions made and quality of life in the survivorship period, especially among very low literacy men.

16 April 2008 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
WCWilliam Corser
William Corser
ASAlla Sikorskii
Alla Sikorskii
AOAde Olomu
Ade Olomu
MSManfred Stommel
Manfred Stommel
CPCamille Proden
Camille Proden
MHMargaret Holmes-Rovner
Margaret Holmes-Rovner
Comorbidity is an important adjustment measure in research focusing on outcomes such as health status and mortality. One recurrent methodological issue concerns the concordance of comorbidity data obtained from different reporting sources. The purpose of these prospectively planned analyses was to examine the concordance of comorbidity data obtained from patient self-report survey interviews and hospital medical record documentation.

17 March 2001 in BMJ
Verified
Journal Article
Closed access
PDF file
MHMargaret Holmes-Rovner
Margaret Holmes-Rovner
HLHilary Llewellyn-Thomas
Hilary Llewellyn-Thomas
VEVikki Entwistle
Vikki Entwistle
ACAngela Coulter
Angela Coulter
AOAnnette O'COnnor
Annette O'COnnor
DRDavid R Rovner
David R Rovner

24 August 2015 in Medical Decision Making
Verified
Journal Article
Closed access
MHMargaret Holmes-Rovner
Margaret Holmes-Rovner
JMJeffrey S. Montgomery
Jeffrey S. Montgomery
DRDavid R. Rovner
David R. Rovner
LSLaura D. Scherer
Laura D. Scherer
JWJesse Whitfield
Jesse Whitfield
AFAngela Fagerlin
Angela Fagerlin
Introduction. Little is known about how physicians present diagnosis and treatment planning in routine practice in preference-sensitive treatment decisions. We evaluated completeness and quality of informed decision making in localized prostate cancer post biopsy encounters. Methods. We analyzed audio-recorded office visits of 252 men with presumed localized prostate cancer (Gleason 6 and Gleason 7 scores) who were seeing 45 physicians at 4 Veterans Affairs Medical Centers. Data were collected between September 2008 and May 2012 in a trial of 2 decision aids (DAs). Braddock’s previously validated Informed Decision Making (IDM) system was used to measure quality. Latent variable models for ordinal data examined the relationship of IDM score to treatment received. Results. Mean IDM score showed modest quality (7.61±2.45 out of 18) and high variability. Treatment choice and risks and benefits were discussed in approximately 95% of encounters. However, in more than one-third of encounters, physicians provided a partial set of treatment options and omitted surveillance as a choice. Informing quality was greater in patients treated with surveillance (β = 1.1, p = .04). Gleason score (7 vs 6) and lower age were often cited as reasons to exclude surveillance. Patient preferences were elicited in the majority of cases, but not used to guide treatment planning. Encounter time was modestly correlated with IDM score (r = 0.237, p = .01). DA type was not associated with IDM score. Discussion. Physicians informed patients of options and risks and benefits, but infrequently engaged patients in core shared decision-making processes. Despite patients having received DAs, physicians rarely provided an opportunity for preference-driven decision making. More attention to the underused patient decision-making and engagement elements could result in improved shared decision making.